Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Search results

1-10 results from 959 for query «cipla»

7 January, 2019 4:58 AM Cadila, Cipla shares gain after HSBC upgrades to buy

HSBC said risk-reward turned favourable post corrections in Cadila Healthcare & Cipla. Cadila Healthcare shares gained 0.6 percent and Cipla 0.8 percent in morning on Monday after global research house HSBC upgraded both stocks to buy. The investment firm said risk-reward turned favourable post corrections in Cadila Healthcare & Cipla. Stocks lost 20 percent 138

13 November, 2018 4:20 PM Cipla acquires US-based Avenue Therapeutics for $215 million

Cipla, India's fourth-largest drug maker on November 13, said its subsidiary , InvaGen Pharmaceuticals has entered into definitive agreements to acquire Nasdaq-listed speciality business firm Avenue Therapeutics for up to $215 million. The acquisition will give Cipla access to specialty drug Tramadol delivered intravenously (IV) to manage post-operative 122

12 November, 2018 5:00 AM Cipla gets USFDA nod for anti-viral eye infection drug for AIDS patients

Valganciclovir tablets are used in the treatment cytomegalovirus infection (serious viral eye infection of the retina) in AIDS patients and in prevention of cytomegalovirus (CMV) disease after organ transplant. Drug major Cipla on Monday said it has received final approval from the US health regulator for Valganciclovir tablets, used in the treatment 102

5 November, 2018 9:04 AM D-Street Buzz: Pharma, media stocks fall with Cipla & Sun TV down 7%; PSU banks gain

The breadth of the market favoured the declines with 801 stocks advancing and 926 declining while 347 remained unchanged. On the BSE, 1184 stocks advanced, 1356 declined and 158 remained unchanged. The Indian stock market continues to trade in the red with the Nifty50 shedding 59 points, trading at 10,493 while the Sensex is down 127 points at 34,884. Nifty 103

30 October, 2018 7:00 AM D- Street Buzz: Nifty energy drags with RIL down 2%; DHFL rallies, Infosys gains

From the BSE smallcap space, the top gainers are Udaipur Cement followed by Jindal Worldwide and Emami Infra while Plastiblends India, Supreme Petrochem and Snowman Logistics are the top losers. The Indian benchmark indices have turned negative in this afternoon session with the Nifty50 down 12 points, trading at 10,238 while the Sensex shed 86

29 October, 2018 6:03 AM Cipla gets USFDA nod for hypertension, cardiac drug

Drug major Cipla on Monday said it has received final approval from the US health regulator to market Metoprolol tablets, used to treat hypertension and various cardiac conditions. The company has received final nod from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Metoprolol ER tablets in the strengths 101

16 October, 2018 7:05 AM D-Street Buzz: PSU bank continue to gain led by BoB; pharma, FMCG stocks drag

The benchmark indices are trading higher but off day's high in the Tuesday afternoon With Sensex gained over 200 points, while Nifty trading above 10,550 mark. Among the sector barring pharma and FMCG all other sectoral indices are trading with up to 1.5 percent gain led by Nifty PSU banks. In the FMCG pack United Spirits, ITC, United Breweries, Tata Global 68

9 August, 2018 4:31 AM D-Street Buzz: Pharma, PSU Bank stocks gain; Selan Exploration hits 52-week high

The Indian benchmark indices hit record highs in opening trade on Thursday with Sensex climbed 38,000 for the first time, while Nifty50 inched towards 11,500. Nifty Bank also hit the record high in the morning trade, led by stocks like ICICI Bank gained 4 percent, Bank of Baroda up 1.3 percent, PNB up 1.7 percent and SBI up 1.5 percent. From oil and gas space 124

8 August, 2018 11:12 AM Cipla Q1 Profit Jumps 10%, Beats Analysts' Estimates

Drugmaker Cipla Ltd posted quarterly profit well above analysts' expectations, helped by strong growth in the domestic market. Net profit rose 10.4 per cent from a year earlier to Rs 451 crore ($65.67 million) in the first quarter ended June 30, the country's third-largest drugmaker by market capitalisation said on Wednesday. This compared with an average 91

19 July, 2018 10:13 AM Sensex, Nifty Close Marginally Lower; Pharma, IT Stocks Lead Losses

Top laggards on the 50-scrip Nifty were Hindalco, Kotak Mahindra Bank, Larsen & Toubro, Cipla and Dr Reddy's Laboratories. Domestic stock markets finished Thursday's session on a sluggish note, with the BSE Sensex closing 22 points lower. National Stock Exchange (NSE) benchmark index Nifty settled at 10,957, down 23 points. The key indices were dragged 109